Market Overview

Earnings Scheduled For July 2

Related AYI
Stocks Hitting 52-Week Highs
Acuity Brands Buys DGLogik
Related AGN
The Lowdown On Activist Investing
Benzinga's M&A Chatter for Wednesday July 27, 2016
VistaGen Is An Interesting Opportunity, Following Allergan's Anti-Depressant Investment In Naurex (Seeking Alpha)

Acuity Brands (NYSE: AYI) is estimated to report its Q3 earnings at $0.78 per share on revenue of $491.70 million.

Allergan (NYSE: AGN) is expected to post its Q2 EPS at $1.06 on revenue of $1.51 billion.

Posted-In: Earnings ScheduledEarnings News Pre-Market Outlook Markets


Related Articles (AGN + AYI)

View Comments and Join the Discussion!